170 likes | 564 Views
Ovarian Hyperstimulation Syndrome (OHSS). Known risk of FSH treatment for infertilityOvarian enlargement, shifts in body fluidsSelf limited in patients who do not conceiveUncommon, but potentially fatal during early pregnancyHow can we prevent or limit OHSS?. Who is at risk?. Polyfollicular ovaries (high oocyte number)High estradiol concentration during ovarian stimulationLarge number of growing follicles during ovarian stimulation.
E N D
1. Outcomes of Elective Cryopreservation of All Embryos in Women at High Risk of Developing Ovarian Hyperstimulation Syndrome Kelly S. Wiersema, MD
Douglas C. Daly, MD
Grand Rapids Medical Education and Research Center
Michigan State University College of Human Medicine
Grand Rapids, Michigan
2. Ovarian Hyperstimulation Syndrome(OHSS) Known risk of FSH treatment for infertility
Ovarian enlargement, shifts in body fluids
Self limited in patients who do not conceive
Uncommon, but potentially fatal during early pregnancy
How can we prevent or limit OHSS? Release of vasoactive substances by the ovaries under hCG stimulation is key in triggering the syndrome.
Massive shifts of fluid from intravascular compartment to 3rd space causing intravascular depletion and hemoconcentration.Release of vasoactive substances by the ovaries under hCG stimulation is key in triggering the syndrome.
Massive shifts of fluid from intravascular compartment to 3rd space causing intravascular depletion and hemoconcentration.
3. Who is at risk? Polyfollicular ovaries (high oocyte number)
High estradiol concentration during ovarian stimulation
Large number of growing follicles during ovarian stimulation Rates of severe OHSS are 0.5 to 2%.Rates of severe OHSS are 0.5 to 2%.
4. Pregnancy and OHSS Becoming pregnant during a stimulation cycle can exacerbate and prolong the syndrome
Endogenous or exogenous human chorionic gonadotropin (hCG) influences the duration and severity of the syndrome Critical event in development of OHSS is administration of hCG.
Moderate or severe OHSS will typically present in luteal phase secondary to ovulatory hCG or in early gestation from endogenous hCG production.
If no pregnancy is established, syndrome rapidly resolves with onset of menses and rarely progresses to severe form.
If pregnancy is established, exacerbation of the syndrome is seen and can persist for up to 12 weeks gestation and is more often seen with multiple gestations.Critical event in development of OHSS is administration of hCG.
Moderate or severe OHSS will typically present in luteal phase secondary to ovulatory hCG or in early gestation from endogenous hCG production.
If no pregnancy is established, syndrome rapidly resolves with onset of menses and rarely progresses to severe form.
If pregnancy is established, exacerbation of the syndrome is seen and can persist for up to 12 weeks gestation and is more often seen with multiple gestations.
5. Cryopreservation of All Embryos Patient undergoes oocyte retrieval and fertilization
All viable embryos are then cryopreserved
The risk of pregnancy is eliminated in the stimulation cycle
Patient undergoes transfer of embryos in future, nonstimulated cycle
6. Research Question What are the pregnancy outcomes of these patients?
Hypothesis
Initiation of pregnancy and pregnancy outcome will be as good for patients undergoing cryopreservation of all embryos when compared to patients at risk for OHSS who undergo fresh transfer of embryos in the stimulated cycle.
7. Methods Retrospective chart review
Private IVF clinic in Grand Rapids, MI
8. Study group Charts reviewed from January 2000 to October 2007
Patients considered to be at risk for and/or exhibiting signs/symptoms of OHSS
Cryopreservation of all embryos
Subsequent frozen transfer in future nonstimulated cycle
33 patients with
9. Control Group Charts reviewed from January 2004 to August 2006
Patients with a peak estradiol concentration of 4000pg/ml or greater
Thought NOT to be at risk and/or signs of hyperstimulation syndrome
Fresh transfer of embryos in the stimulated cycle
41 patients
10. Outcomes Clinical pregnancy rate per patient and transfer
Livebirth rate per patient and transfer
Multiple pregnancy rate
Rates of moderate or severe OHSS
11. Results
12. Results
13. Clinical Pregnancy Rate
14. Livebirth Rate
15. Multiple Pregnancy Rate Fresh transfer: 5 twins, 1 triplet
Cryopreservation: 8 twins, 3 tripletsFresh transfer: 5 twins, 1 triplet
Cryopreservation: 8 twins, 3 triplets
16. Discussion Cochrane review in 2002 showed insufficient evidence to support cryopreservation
Some studies have shown inferior pregnancy rates when all embyros were cryopreserved and patients underwent frozen embryo transfer
Other strategies have been used to try and prevent OHSS
Cycle cancellation, IV albumin, withholding gonadotropin administration (coasting)Cycle cancellation, IV albumin, withholding gonadotropin administration (coasting)
17. Discussion This study shows excellent pregnancy and livebirth rates
Rates of moderate and severe OHSS in the study group were high
Duration of OHSS was short (resolved by LPD #12) and all patients treated as outpatients
18. Conclusion Potentially higher, though not statistically significant, increase in pregnancy and livebirth rates
Given the excellent pregnancy rates, this is a viable option to manage patients at high risk of OHSS
Need further studies with larger number of patients, and prospective trials